Question

complete the knowledge check by day 7 of week 9. walden university question 1 1 pts which formulation of buprenorphine is used for extended - release treatment of opioid use disorder?
o oral tablet
o nasal spray
o intramuscular injection
o subcutaneous injection

Explanation:

Buprenorphine for extended - release treatment of opioid use disorder is available as a subcutaneous injection (brand name Sublocade). Oral tablets, nasal sprays, and intramuscular injections are not the extended - release formulation for this purpose.

Answer:

D. Subcutaneous injection